Business Context and Reporting Period
Company: Strive, Inc. (Nasdaq: ASST)
Filing Type: Form 8-K (Current Report)
Date of Report: September 23, 2025
Event: Disclosure of a pending all-stock merger with Semler Scientific, Inc. The Merger Agreement was entered into on September 22, 2025, following unanimous board approval from both companies on September 21, 2025.
Key Financial Metrics
This filing does not contain specific revenue, profit, cash flow, or debt figures for Strive, Inc. or the combined entity within the text body. Financial data is provided via incorporated exhibits:
- Semler Scientific Historical Data: Audited statements for fiscal years ended December 31, 2024 and 2023 (Exhibit 99.1) and unaudited interim statements for periods ended June 30, 2025 (Exhibit 99.2).
- Pro Forma Information: Unaudited combined financial information assuming the merger closed on January 1, 2024 (statement of operations) and June 30, 2025 (balance sheet) is included in Exhibit 99.3.
- Transaction Structure: All-stock acquisition.
Material Changes and Transaction Details
The primary material change is the execution of the Merger Agreement to acquire Semler Scientific. The filing incorporates:
- Historical financial statements of Semler Scientific.
- Unaudited pro forma combined consolidated financial information.
- Supplementary risk factors related to the merger.
- Failure to satisfy closing conditions or termination of the agreement.
- Integration difficulties, costs, and diversion of management attention.
- Dilution from the issuance of additional Class A common stock.
- Risks associated with Bitcoin treasury strategies and digital assets.
- Adverse reactions from customers, employees, or changes in share price.
- Legal proceedings against either party or the combined company.
- Review the definitive Information Statement/Proxy Statement/Prospectus (Form S-4) for detailed transaction terms and voting instructions.
- Examine Exhibit 99.3 for unaudited pro forma financial data to understand the projected combined financial position.
- Verify the specific terms of the all-stock exchange ratio and potential dilution impact.
- Assess the risks related to Bitcoin treasury strategies mentioned in the supplementary risk factors (Exhibit 99.4).
- Monitor the status of regulatory approvals and stockholder votes required to close the transaction.
Strive explicitly states that this report does not modify or update its own consolidated financial statements previously filed in periodic reports.
Guidance, Outlook, and Risks
Outlook and Forward-Looking Statements: The filing contains extensive forward-looking statements regarding the strategic and financial benefits of the transaction, integration plans, and timing. Management cautions that actual results may differ materially due to uncertainties.
Key Risks Identified:
Next Steps: Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholder approval.